Kestra Medical Technologies, Ltd.
KMTS
$20.41
-$0.75-3.54%
| Weiss Ratings | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -6.55% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -11.07% | |||
| 52-Week Low % Change | 2.05% | |||
| Price | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $22.95 | |||
| 52-Week Low Price | $20.00 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Mar 06, 2025 | |||
| Valuation | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.01B | |||
| Enterprise Value | 1.28B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -434.35 | |||
| Earnings Per Share Growth | -13.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.08 | |||
| Price/Book (Q) | -0.01 | |||
| Enterprise Value/Revenue (TTM) | 46.45 | |||
| Price | $20.41 | |||
| Enterprise Value/EBITDA (TTM) | -38.33 | |||
| Enterprise Value/EBIT | -34.00 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 105.80K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 425 279 8002 | |||
| Address | 3933 Lake Washington Blvd NE Kirkland, WA 98033 | |||
| Website | kestramedical.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $259.85 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 189.91% | |||
| Earnings Growth (Q YOY) | 18.47% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 13.50% | |||
| Balance Sheet | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 76.92M | |||
| Cash Per Share (Q) | $727.01 | |||
| Total Current Assets (Q) | 87.93M | |||
| Total Preferred Equity (Q) | 280.51 | |||
| Total Equity (Q) | 43.97M | |||
| Current Ratio (Q) | 2.808 | |||
| Book Value Per Share (Q) | -$2,390.68 | |||
| Total Assets (Q) | 121.45M | |||
| Total Current Liabilities (Q) | 31.31M | |||
| Total Debt (Q) | 46.10M | |||
| Total Liabilities (Q) | 77.49M | |||
| Total Common Equity (Q) | -252.95M | |||
| Cash Flow | KMTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
